Clinical Trial Results:
A Phase III, Randomized, Double-Blind, Active-Controlled,
Parallel-Group Study, Conducted Under In-House Blinding Conditions,
to Examine the Safety, Tolerability, and Efficacy of a
Single Dose of Intravenous MK-0517 for the Prevention of
Chemotherapy-Induced Nausea and Vomiting (CINV) Associated
With Cisplatin Chemotherapy
Summary
|
|
EudraCT number |
2007-004043-30 |
Trial protocol |
SE ES IT HU PT PL NL LT DK DE |
Global completion date |
29 Jun 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Apr 2016
|
First version publication date |
28 Apr 2016
|
Other versions |
|
Summary report(s) |
clinicaltrials.gov record including results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.